SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001168220-15-000083
Filing Date
2015-08-28
Accepted
2015-08-28 15:49:06
Documents
5

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/AMENDMENT #5 - IPMD 08/28/2015 sc13da-ipmd_082815.htm SC 13D/A 57406
2 ASSIGNMENT AGREEMENT, DATED JANUARY 31, 2014 ex_99-1.htm EX-99.1 124600
3 STOCKHOLDERS' AGREEMENT, DATED JANUARY 31, 2014 ex_99-2.htm EX-99.2 119274
4 EQUALIZATION AGREEMENT, DATED JANUARY 31, 2014 ex_99-3.htm EX-99.3 91399
5 AMENDMENT TO STOCKHOLDERS' AGREEMENT, DATED JULY 27, 2015 ex_99-4.htm EX-99.4 21607
  Complete submission text file 0001168220-15-000083.txt   415860
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Subject) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79412 | Film No.: 151082123
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ULURU INC. 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address SCHREYVOGELGASSE 3/5 VIENNA C4 1010AT 214-505-5145
IPMD GmbH (Filed by) CIK: 0001567515 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A